SPARK

Funded Partner

SPARK has a special focus on the often-neglected diseases, including those in the area of Child and Maternal Health. Thanks to funding from the Stanford Maternal and Child Health Research Institute, 18 projects in this area have reached the clinic or commercial sectors.

SPARK is a unique partnership between the University and industry experts. Building upon Stanford’s tradition of technological innovation and entrepreneurship, Chemical and Systems Biology Professor, Daria Mochly-Rosen, founded the SPARK program, and joined by Professor Kevin Grimes later in the first year, to provide a cost-effective model to generate proof of concept using out-of-the-box academic approaches combined with industry standards.

SPARK provides access to specialized knowledge and technical expertise regarding drug and diagnostic development, dedicated core laboratory facilities, and sources of funding to support translational efforts.


FY 2021 Awards

Eric Appel, PhD
Assistant Professor, Materials Science & Engineering
Study Title: An Ultra-Fast Insulin to Improve the Treatment of Diabetes

Maria Barna, PhD
Associate Professor, Genetics
Assistant Professor, Materials Science & Engineering
Study Title: Identifying Translational Activators for the Treatment of Diamond Blackfan Anemia

Vivek Bhalla, MhD, Associate Professor, Medicine (Nephrology)
Study Title: Gene Therapy for Autosomal Dominant Polycystic Kidney Disease

Ami Bhatt, MD, PhD
Assistant Professor, Medicine (Hematology)
Study Title: Developing Novel Microbial Integrases as Next-Generation Gene Therapies

Kelly Mahaney, MD, MS, Assistant Professor, Neurosurgery
Study Title: Development of Iron Chelation Intraventricular Drug Delivery for Prevention of Post-Hemorrhagic Hydrocephalus (PHH) in Severe Neonatal Intraventricular Hemorrhage (IVH)

Past Awards